ReviewJournal of managed care & specialty pharmacy2020

The Effectiveness and Value of Rivaroxaban and Icosapent Ethyl as Additive Therapies for Cardiovascular Disease.

Patricia G Synnott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.